On February 15, patients, doctors and researchers come together to celebrate facing cancer and overcoming healthcare disparities

Boston, MA (January 17, 2023) – GBH WORLD and Count Me In, a nonprofit initiative that engages patients to accelerate cancer research, are partnering to create a live storytelling event that spotlights true experiences with cancer, healthcare disparities and the power of self-advocacy.

On Wednesday, February 15, 2023, Stories from the Stage: Living with Cancer will bring together patients, doctors and researchers with direct experience in cancer detection, treatment and survival for a special evening of live storytelling at GBH Studios in Brighton, Massachusetts. Produced by GBH WORLD, public media’s premier platform for diverse stories, Stories from the Stage, the multi-platform award-winning series, invites ordinary people to share extraordinary experiences.

Stories from the Stage: Living with Cancer will be an uplifting evening of transformational storytelling from those who have faced cancer as well as those working for cancer equity initiatives capable of unlocking discoveries for all patients. The stories will be broadcast as two new episodes of Stories from the Stage on Monday, June 5 and Monday, June 12 for National Cancer Survivors Month on GBH 2 locally and on 191 WORLD Channel stations nationally.

This event is presented in partnership with Count Me In, a nonprofit research initiative that hopes to make every patient's experience count in the fight to overcome cancer. Founded in 2018 by the Emerson Collective, Broad Institute of MIT and Harvard, as well as the Dana-Farber Cancer Institute, Count Me In empowers patients to accelerate cancer research by sharing their experiences, clinical information and even samples. To learn more, visit JoinCountMeIn.org.

“Live storytelling has the power to astonish - make us laugh, cry and open our hearts to new experiences,” said Liz Cheng, GBH General Manager for Television and Co-Executive Producer of Stories from the Stage. “We are so fortunate to work with our partner, Count Me In, to help us discover tellers from underrepresented communities, who share how their struggles and triumphs have changed the trajectories of their lives and others dealing with cancer.”

“This partnership provides a wonderful and unique opportunity to lift up the most marginalized voices - to bring the stories of patients, loved ones, and beyond - to the public in a most impactful way,” said Colleen Nguyen, Manager of Community Engagement and Cancer Equity at Count Me In.

Stories from the Stage: Living with Cancer takes place Wednesday, February 15 at 6:30pm at GBH Studios in Brighton. Tickets for the live taping are $50 and can be purchased at wgbh.org/events.

###

About WORLD Channel
WORLD shares the best of public media in news, documentaries and programming. WORLD’s original series examine the issues and amplify the voices of those often ignored by mainstream media. The multicast 24/7 channel helps audiences understand conflicts, movements and cultures from around the globe. Its original work has won a Peabody Award, an Alfred I. duPont-Columbia Award, a National News and Documentary Emmy Award, a Webby Award, an IDA Documentary Award and many others honoring diversity of content and makers. WORLD is carried by 191 member stations in markets representing 74% of US TV households. Funding for WORLD Channel is provided by the Corporation for Public Broadcasting, the John D. and Catherine T. MacArthur Foundation, Wyncote Foundation and the National Endowment for the Arts and Artworks. WORLD is produced by GBH in partnership with WNET and is distributed by American Public Television (APT). Find out more at WORLDChannel.org.

About Count Me In
Count Me In (CMI) is a 501(c)3 nonprofit research initiative on a mission to make every patient's experience count in the effort to understand and overcome cancer. Founded in 2018 by Emerson Collective and Broad Institute of MIT and Harvard, and Dana-Farber Cancer Institute, Count Me In engages patients and enables them to accelerate cancer research by sharing their samples, clinical information, and voices. From their contributions, Count Me In analyzes and shares de-identified data freely to catalyze discoveries across cancer. Data generated by Count Me In is shared regularly via scientific platforms so that it can be harnessed by researchers everywhere to make impactful discoveries. All individuals living with cancer, including those from marginalized communities who have historically been excluded from research, no matter where they live, can contribute to breakthroughs and increase the pace of biomedical research.